MARIA DZIEKAN: Open Payments
NPI 1891311239 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,247 in 104 payments from 14 companies in 2025. Trend: 2023 $1,299 · 2024 $1,768 · 2025 $2,247
Food & beverage: $2,247
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $588 |
| Regeneron Healthcare Solutions, Inc. | 26 | $527 |
| GENZYME CORPORATION | 19 | $337 |
| GlaxoSmithKline, LLC. | 12 | $238 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Amgen Inc. | 5 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Ionis Pharmaceuticals, Inc. | 2 | $45 |
| Organon LLC | 1 | $35 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, NUCALA, AIRSUPRA, NEFFY, TRELEGY ELLIPTA, EOHILIA.
Industry payments across NY — which companies pay providers there.
